COMMUNIQUÉS West-GlobeNewswire

Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
22/10/2025
Nasir Khan, DVM, Ph.D.: Senior Vice President of Preclinical Development Gary Ingenito, MD, Ph.D.: Senior Vice President of Clinical Development WALTHAM, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Sironax, a global [...]
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
22/10/2025
EMERYVILLE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, [...]
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
22/10/2025
PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll approximately 2,500 [...]
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
22/10/2025
CONSHOHOCKEN, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
22/10/2025
BRISBANE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
22/10/2025
Company to host shareholder webinar today, October 22, 2025, at 2:00 PM ET to review execution milestones, pipeline progress, and capital strategy WESTLAKE VILLAGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
22/10/2025
Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis LA JOLLA, Calif., Oct. 22, 2025 (GLOBE [...]
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
22/10/2025
AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous [...]
The Future of Discovery: Science News Spotlights Scientists to Watch
22/10/2025
WASHINGTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- For the past nine years, Science News has celebrated early-career scientists tackling some of today’s biggest challenges. The Science News’ Scientists to Watch 2025 list [...]
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
22/10/2025
The Company will Host a Conference Call and Webcast on Thursday, November 6, 2025, at 8:30 AM ET CORAL GABLES, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: [...]
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
22/10/2025
ALAMEDA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today [...]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
22/10/2025
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within [...]
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
22/10/2025
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage to ~35% of European Union population with ~300,000 [...]
24/7 Market News- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection
22/10/2025
DENVER, Oct. 22, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, believes that Kraig Biocraft Laboratories’ (OTCQB: [...]
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
22/10/2025
CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
Wake-Up Call: Aeroflow Sleep Survey Reveals a Growing Gap in Sleep Health Education and the Rise of DIY Sleep Trends
22/10/2025
New survey of 1,884 adults finds 81% struggle with sleep while 60% try unvetted online trends without medical consultation ASHEVILLE, N.C., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aeroflow Sleep, a national durable medical [...]
Aeroflow Health Wins 2025 HME Provider of the Year Award
22/10/2025
Aeroflow Health's innovative approach to patient access, technology integration and partnership development sets a new standard for the home medical equipment industry ASHEVILLE, N.C. and CLEVELAND, Oct. 22, 2025 (GLOBE [...]
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
22/10/2025
Co-led b y Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed by Elevara from Japan’s Teijin Pharma with good tolerability and [...]
Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium
22/10/2025
Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and P53 Y220C reactivator Candidates for FGFR3 and SMARCA2 programs identified [...]

Pages